NFATC1 and cancer: The pivotal role of NFATc1 in the activation of EMT transcriptional programs in cancer cells and the availability of specific small molecule inhibitors (e.g. CsA or VIVIT) renders this factor very interesting as a potential drug target to increase conventional therapies efficiency [71, 72].